GL1X · GenesisL1 explorer

MolNFT v1 · #57428 · protein

Crystal structure of TLR2-pe-dtpa complex

3A7C · Toll-like receptor 2, variable lymphocyte receptor B: “Crystal structure of TLR2-pe-dtpa complex”. X-ray diffraction, 4 ligands (PDK, NAG, MAN), 1 pocket (best druggability 0.84). MolNFT v1 #57428 on GenesisL1: 3D structure, binding…

PDB
3A7C
Type
protein
Length
549 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Toll-like receptor 2, variable lymphocyte receptor B
UniProt
Q9QUN7, Q4G1L2
Ligands
PDK, NAG, MAN, LU
Pockets
1 · best druggability 0.84

Structure

x-ray diffraction · 1 distinct chain · 13% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AToll-like receptor 2, variable lymphocyte receptor Bprotein54913% helix, 20% strandQ9QUN7, Q4G1L2

Ligands and binding sites

  • PDK · (10S,13R)-3-{2-[{2-[bis(carboxymethyl)amino]ethyl}(carboxymethyl)amino]ethyl}-10-hydroxy-5,16-dioxo-13-(tetradecanoyloxy)-9,11,15-trioxa-3,6-diaza-10-phosphanonacosan-1-oic acid 10-oxide · ligand · chains A
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 5 copies · chains A
  • MAN · alpha-D-mannopyranose · sugar
  • LU · Lutetium (III) ion · metal

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18400.840.8562PDK

Modifications

Observed in the structure: 5 disulfide, 2 glycan (disulfide, N-glycosylation).

Compared structures

  • 3A7C · Crystal structure of TLR2-PE-DTPA complex · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9QUN7 · AlphaFold monomer V2.0 prediction for toll-like receptor 2 (Q9QUN7) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.